RACHEL HARVEY: Open Payments
NPI 1649950577 · CHARLESTON, WV. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,545 in 64 payments from 13 companies in 2025. Trend: 2023 $463 · 2024 $2,488 · 2025 $1,545
Food & beverage: $1,528Education: $17
| Company | Payments | Amount |
|---|---|---|
| Regeneron Healthcare Solutions, Inc. | 11 | $348 |
| Insmed, Inc. | 13 | $272 |
| Verona Pharma, Inc. | 9 | $215 |
| GENZYME CORPORATION | 3 | $161 |
| GlaxoSmithKline, LLC. | 9 | $160 |
| Axsome Therapeutics, Inc. | 5 | $125 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 3 | $69 |
| AstraZeneca Pharmaceuticals LP | 4 | $60 |
| Amgen Inc. | 2 | $32 |
| Merck Sharp & Dohme LLC | 2 | $31 |
Products named: DUPIXENT, Arikayce, Ohtuvayre, Sunosi, NUCALA, JASCAYD, TRELEGY ELLIPTA, TEZSPIRE.
Industry payments across WV — which companies pay providers there.
